10-Q: Gyrodyne Net Assets Rise Amidst Liquidation Progress

Gyrodyne, LLC reports an increase in net assets and estimated per-share distributions, driven by real estate value gains and a new property sale agreement, despite ongoing legal challenges and an extended liquidation timeline.

Summary

• Net assets in liquidation increased to $32,608,865 as of June 30, 2025, up from $30,596,313 on December 31, 2024.
• Estimated liquidating distributions per common share rose to $14.83 from $13.91, based on 2,199,308 shares outstanding.
• The increase in net assets is primarily due to a $4,502,000 increase in real estate value and a $252,000 net increase in revenues from leasing activity.
• A Purchase and Sale Agreement was signed on July 30, 2025, for approximately 49 acres of Flowerfield vacant land to B2K Smithtown LLC, with a purchase price between $24,000,000 and $28,740,000.
• The estimated value of the B2K contract is $28,740,000, contingent on site plan approval.
• The estimated timeline to complete the liquidation has been extended to December 31, 2027, due to the contingencies of the B2K agreement.
• Ongoing legal proceedings, specifically the Article 78 Proceeding related to the Flowerfield subdivision, continue to be vigorously defended, with multiple appeals filed by petitioners.
• The company incurred approximately $167,000 in land entitlement costs during the six months ended June 30, 2025, with an estimated $1,274,000 remaining through the end of liquidation.
• Cash and cash equivalents stood at $5,480,958 as of June 30, 2025.
• Loans payable totaled $11,020,200 as of June 30, 2025.
• Leasing activity during the six months ended June 30, 2025, included 3 new leases and 2 renewals (5,200 sq ft, $105,000 annual revenue), 5 expansions (2,400 sq ft, $37,000 annual revenue), and 1 termination (1,000 sq ft, $18,000 annual revenue).

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While there's clear progress with increased net assets, a signed sales agreement, and legal victories, the extended liquidation timeline, persistent legal appeals, and ongoing macroeconomic headwinds introduce significant uncertainty and risk. The activist shareholder situation also adds a layer of potential distraction and cost.

Positives

• Net assets in liquidation increased by $2,012,552, leading to a higher estimated distribution per share of $14.83.
• The value of real estate held for sale increased by $4,502,000, reflecting progress in entitlement efforts and market conditions.
• A significant Purchase and Sale Agreement for a portion of the Flowerfield property was executed for an estimated $28,740,000, marking a concrete step towards asset disposition.
• The Cortlandt Manor property received Medical Oriented Zoning District (MOD) designation for 154,000 square feet, enhancing its development flexibility and potential value.
• The company successfully defended against multiple legal challenges in the Article 78 Proceeding, with the Supreme Court dismissing the original petition and denying motions to renew/reargue and stay enforcement.
• Leasing activity showed positive trends with new leases and expansions, contributing to a net increase in revenues of approximately $252,000.

Negatives

• The liquidation timeline has been extended to December 31, 2027, indicating a longer period until final distributions.
• The B2K Purchase and Sale Agreement is subject to significant contingencies, including subdivision and site plan approval, which may take years or not be obtained.
• The company expects to continue incurring operating losses and has a limited cash runway of approximately 18 months without further real estate sales.
• Ongoing legal appeals in the Article 78 Proceeding introduce uncertainty and could further delay the sale of the Flowerfield property.
• The company faces risks from activist shareholders, specifically Star Equity Fund, LP, which intends to nominate directors, potentially leading to a costly and distracting proxy contest.
• Macroeconomic factors such as elevated interest rates, persistent inflation, and constrained capital from lending institutions continue to weaken commercial real estate markets.
• The company's estimates for net realizable value and liquidation costs are subject to inherent uncertainty and could materially change, potentially reducing distributions to shareholders.
• A related party lease agreement with a not-for-profit organization, where the Chairman serves as a director, is at a below-market rate, potentially impacting rental income.

Risks

• The sale of a significant portion of the Flowerfield property is contingent on receiving subdivision and site plan approval, which may take years or may not be obtained at all.
• The company expects to continue incurring operating losses and has limited cash resources, sufficient for approximately 18 months without further real estate sales.
• The company is subject to risks associated with proxy contests and other actions of activist shareholders, which can be costly, time-consuming, and disrupt operations.
• Perceived uncertainties about the company's future direction due to activist campaigns may result in the loss or compromise of potential opportunities to liquidate properties for maximum value.
• A successful proxy contest could result in a change of control of the Board, potentially triggering contractual obligations under material agreements.
• If nominees advanced by activist shareholders are elected with a specific agenda, it may adversely affect the ability to effectively and timely implement the strategic plan.
• Proxy contests may cause the stock price to experience periods of volatility.
• The COVID-19 pandemic may continue to adversely impact the timeliness of local government in granting required approvals, causing delays in entitlement efforts.
• The pandemic has resulted in a significant shift toward commercial acceptance of remote working and telemedicine, which may adversely impact occupancy rates and average rates per square foot for commercial properties.
• Elevated interest rates and persistent inflation have contributed to continued weakness in commercial real estate markets.
• Regulated lending institutions are constrained in providing capital for commercial real estate properties due to increased capital requirements.
• There is no assurance that value enhancement efforts will result in property value increases that exceed the costs incurred in such efforts, or even any increase at all.
• The ultimate amount of proceeds that will actually be distributed to shareholders or the timing of such payments cannot be determined with certainty.
• If available cash and proceeds from asset sales are not adequate to cover obligations, liabilities, expenses, and claims, distributions to shareholders could be eliminated.
• Shareholders could be held liable for payments made to them and required to return distributions if there are insufficient funds to pay creditors after distributions.
• The healthcare industry, to which the company's tenants are exposed, is subject to substantial regulation and cost controls, which could impact tenants' ability to pay rent.
• Competition and loss of referrals could adversely affect healthcare tenants' ability to make rental payments, impacting rental revenues.
• Increased regional concentration in tenants as assets are sold will increase credit risk from exposure to local economies.
• There is no assurance that the company's leases will renew for the same square footage, at favorable rates, or at all.

Future Outlook

The company's future outlook is centered on completing its liquidation strategy by December 31, 2027. This involves aggressively marketing its remaining properties (Flowerfield and Cortlandt Manor), pursuing entitlements to maximize their sale value, and negotiating purchase agreements. The company anticipates receiving subdivision approval for Flowerfield in Q4 2025 and for Cortlandt Manor in late 2026. Future purchase agreements are expected to include subdivision and site plan approval as closing conditions, which the company believes can be pursued simultaneously. The company intends to modify existing loan terms to ensure sufficient capital through the extended liquidation period and expects to make distributions to shareholders upon asset disposition and liability settlement.

Management Comments

• "Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report."
• "Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report."
• "Gyrodyne remains confident in its defense of the appeal, the motion to renew and reargue and the motion to appeal the denial of the Petitioners motion to stay enforcement of the order."
• "Although Gyrodyne believes that selling individual lots will maximize value, it is also pursuing prospective purchasers who may be willing to purchase all of Flowerfield as an undivided parcel on terms that Gyrodyne finds more attractive from a timing and value perspective."
• "The Board and Management believe the aforementioned strategy will increase the aggregate value for such properties as a whole."
• "We remain committed to (1) enhancing the net value of Flowerfield and Cortlandt Manor to maximize the returns for our shareholders, (2) completing the disposition of our assets, (3) making timely distributions to our shareholders, (4) managing capital and liquidity, (5) mitigating risks relating to interest rates and real estate cycles and (6) completing the liquidation of the Company."
• "The Company believes the commitment of these resources will enable the Company to position the properties for sale with all entitlements necessary to maximize the aggregate Flowerfield and Cortlandt Manor property values and resulting distributions."
• "The Company does not intend to develop the properties but rather to commit resources to position the properties for sale in a timely manner with all entitlements necessary to achieve increased development flexibility."

Industry Context

The commercial real estate market, particularly in New York, continues to face headwinds from elevated interest rates, persistent inflation, and constrained capital from lending institutions. The shift towards remote working and telemedicine also impacts demand for office and medical office spaces, though medical offices have shown more resilience. Gyrodyne's strategy of pursuing entitlements to increase development flexibility aims to counteract these challenges by enhancing property value for potential developers, rather than engaging in direct development. The ongoing legal and regulatory delays, exacerbated by pandemic-related backlogs and labor shortages in zoning authorities, are a common challenge in complex real estate development projects.

Comparison to Industry Standards

• The company's strategy of pursuing entitlements to maximize property value for sale, rather than direct development, aligns with a risk-averse approach in a challenging real estate market. This contrasts with traditional developers like RXR Realty or Tishman Speyer who undertake full-scale development, assuming higher risk for potentially higher returns.
• The estimated distribution per share of $14.83, while an increase, is an internal estimate based on liquidation values and subject to significant uncertainties. Direct comparison to market-traded REITs (e.g., Prologis for industrial, Healthpeak Properties for medical office) is difficult as Gyrodyne is in liquidation and not focused on recurring revenue or FFO growth.
• The company's ability to secure a purchase agreement for a significant portion of its Flowerfield property, even with contingencies, indicates some market interest in well-located, entitled land, which is a positive sign compared to broader market stagnation in some commercial real estate segments.
• The prolonged legal battles over subdivision approvals, such as the Article 78 Proceeding, are not uncommon for large-scale land development projects in densely populated areas like New York, where community activism and environmental concerns can significantly delay timelines, similar to challenges faced by projects from developers like Lennar or Toll Brothers in suburban markets.

Corporate Governance

Legal Proceedings

• **Putative Class Action Lawsuit (2015 Settlement):** The company is bound by a 2015 Stipulation of Settlement requiring all property sales to be arm's-length transactions at prices at or above their 2014 appraised values. As of June 30, 2025, the remaining unsold properties' value exceeded their respective 2014 appraised values.
• **Article 78 Proceeding (Flowerfield Subdivision):** An ongoing legal challenge initiated on April 26, 2022, by the Incorporated Village of Head of the Harbor and other parties, seeking to annul the Town of Smithtown Planning Board's preliminary approval of the Flowerfield Subdivision Application. The Supreme Court of New York dismissed the petition in its entirety on October 11, 2024. However, petitioners filed a notice of appeal on October 28, 2024, and a motion to renew and reargue on November 12, 2024 (denied March 21, 2025). Petitioners also appealed the denial of their motion to stay enforcement of the order on April 16, 2025, and perfected their appeal on the original petition on April 28, 2025. The company and the Town of Smithtown are vigorously defending against these appeals, which could extend the process into 2027.
• **Shareholder Nomination:** The company received a notice on June 4, 2025, from Star Equity Fund, LP (claiming 7.1% ownership), indicating its intent to nominate two candidates for election as directors at the 2025 Annual Meeting of Shareholders. This could lead to a contested election if no agreement is reached.

Related Party Transactions

• The company has a Consolidated Lease Agreement with a not-for-profit organization where the company's Chairman, Paul Lamb, serves as Chairman and a director without compensation. The lease, extended to December 2027, is at a below-market rate of $8,829 annually, totaling $44,144 during the extended period. The Chairman's firm, LambZankel, LLP, provided pro bono legal representation to the not-for-profit on this lease. The independent members of the Board approved this transaction.

Stakeholder Impact

• **Shareholders:** Expected to receive higher estimated liquidating distributions ($14.83/share) due to increased net assets, but the extended liquidation timeline and ongoing legal/macroeconomic risks introduce uncertainty regarding the timing and final amount of these distributions. The potential for a contested election could also impact shareholder value and governance.
• **Employees/Management:** Retention bonus plan amendments and the restricted stock plan aim to incentivize and retain key personnel through the liquidation process, aligning their interests with maximizing asset value and shareholder returns. However, the extended timeline means a longer period of uncertainty for their roles.
• **Customers (Tenants):** Leasing activity indicates continued operations and revenue generation from existing tenants. However, macroeconomic conditions and industry-specific challenges (healthcare regulation) could impact tenants' ability to pay rent, potentially affecting the company's cash flow.
• **Creditors:** The company's ability to satisfy its obligations and liabilities depends on the successful disposition of assets. While management believes available cash and asset sale proceeds will be adequate, there's no assurance, and insufficient funds could lead to shareholder liability for distributions.
• **Local Communities/Regulatory Bodies:** The ongoing entitlement process and legal challenges (Article 78 Proceeding) highlight the complex relationship with local planning boards and community groups, impacting development timelines and potentially the final use of the properties.

Next Steps

• Continue vigorous defense against the Article 78 Proceeding appeals and any other motions related to the Flowerfield subdivision.
• Pursue subdivision approval for Flowerfield, expected in Q4 2025.
• Pursue subdivision approval for Cortlandt Manor, expected in late 2026.
• Work towards satisfying conditions and contingencies for the B2K Purchase and Sale Agreement, including site plan approval.
• Aggressively market the remaining Flowerfield and Cortlandt Manor properties to identify viable prospective buyers.
• Negotiate contracts for remaining properties, aiming to pursue subdivision and site plan approval simultaneously with sales.
• Evaluate and potentially modify terms of existing loan facilities to strengthen financial position through the extended liquidation period.
• Manage cash flow from tenant leases and maintain/improve occupancy rates.
• Review operating activities for possible cost reductions and additional capital/credit needs.
• Determine the actual nature, amount, and timing of liquidating distributions to shareholders upon completion of asset disposition and liability settlement.
• Address the shareholder nomination by Star Equity Fund, LP, for the 2025 Annual Meeting, potentially through engagement or a contested election.

Key Dates

Recommendation

The company is in a liquidation phase, making traditional investment metrics less relevant. While the increase in estimated net assets and the signing of a significant purchase agreement are positive developments, the extended liquidation timeline, persistent legal challenges, and the potential for a costly proxy contest introduce considerable uncertainty. The value is tied to the successful and timely disposition of assets, which remains subject to external factors. Investors should hold to see the outcome of the ongoing legal proceedings and the realization of asset sales, as the current estimated distribution per share is an improvement but not guaranteed.

Keywords

Real Estate Liquidation, Property Development, SEC Filing, 10-Q, Commercial Real Estate, Asset Disposition, Shareholder Distributions, Entitlement Process, Legal Proceedings, Proxy Contest, New York Real Estate, Flowerfield, Cortlandt Manor, Real Estate Investment, Corporate Governance